Print Page  |  Close Window

SEC Filings

6-K
TEVA PHARMACEUTICAL INDUSTRIES LTD filed this Form 6-K on 08/03/2017
Entire Document
 


Table of Contents

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Notes to Consolidated Financial Statements – (Continued)

 

     Net Unrealized Gains/(Losses)     Benefit Plans        
     Foreign
currency
translation
adjustments
    Available-
for-sale
securities
    Derivative
financial
instruments
    Actuarial
gains/(losses)
and prior
service
(costs)/credits
    Total  

Balance as of December 31, 2015

   $ (2,384   $ 312     $ 175     $ (58   $       (1,955
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss) before reclassifications

     227       (364     (523     *       (660

Amounts reclassified to the statements of income

     3       98       2       *       103  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net other comprehensive income (loss) before tax

     230       (266     (521     *       (557

Corresponding income tax

     (33     1       —         *       (32
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net other comprehensive income (loss) after tax**

     197       (265     (521     *       (589
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of June 30, 2016

   $ (2,187   $ 47     $ (346   $ (58   $ (2,544
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

* Represent an amount less than $0.5 million
** Amounts do not include foreign currency translation adjustments attributable to non-controlling interests of $149 million gain.

NOTE 11—Debt obligations:

a. Short-term debt:

 

     Weighted average interest
rate as of June 30, 2017
    Maturity      June 30, 2017      December 31, 2016  
            
                  (U.S. $ in millions)  

Term loan JPY 28.3 billion

     JPY LIBOR+0.25%       2018      $ 252      $ —    

Bank facilities

     2.24%       2017        115        15  

Term Loan JPY 6.7 billion

     JPY LIBOR+0.4%       2018        60        —    

Revolving credit facility

     LIBOR+1.125%       2017        40        1,240  

Convertible debentures

     0.25%       2026      514        514  

Term loan JPY 8.0 billion

     JPY LIBOR+0.223%       2017        —          68  

Term loan GBP 510 million

     GBP LIBOR+0.7%       2017        —          629  

Current maturities of long-term liabilities

          265        810  
       

 

 

    

 

 

 

Total short term debt

        $ 1,246      $ 3,276  
       

 

 

    

 

 

 

 

* Net-share settlement feature exercisable at any time.

 

19